Filing Details

Accession Number:
0001140361-17-029599
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-01 16:26:20
Reporting Period:
2017-08-01
Filing Date:
2017-08-01
Accepted Time:
2017-08-01 16:26:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656328 Sienna Biopharmaceuticals Inc. SNNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1430423 D Richard Peterson C/O Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road, Suite 140
Westlake Village CA 91362
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-01 7,000 $15.00 7,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's initial public offering at the offering price of $15.00 per share.